Venus Remedies Limited (VENUSREM.NS) NSE

731.90

-32.25(-4.22%)

Updated at December 05 12:52PM

Currency In INR

Valuation

Market Cap4.23B
Enterprise Value3.44B
P/E Ratio18.12
PEG Ratio0.98
Price/Sales Ratio1.45
Price/Book Ratio1.74
Enterprise/Revenue1.45
Enterprise/EBITDA9.7

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.06

Management Effectiveness

Return On Assets0
Return On Equity0.1

Income Statement

Revenue6.48B
Revenue/Share501.99
Gross Profit1.66B
EBITDA944.1M
Net Income453.2M
Diluted EPS33.9

Balance Sheet

Total Cash1.56B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share419.54

Price History

52-Week Change123.21
52-Week High799.8
52-Week Low270.25
Moving Average 50 Days518.87
Moving Average 200 Days430.55

Statistics

Average Volume93,428
Shares Outstanding13.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A